STAGE III ENDOMETRIAL CANCER

Clinical trials for STAGE III ENDOMETRIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new STAGE III ENDOMETRIAL CANCER trials appear

Sign up with your email to follow new studies for STAGE III ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

Hormone blocker plus targeted drug shows promise against tough uterine cancer

Disease control Not yet recruiting

This phase II trial tests whether combining elacestrant, a drug that lowers estrogen, with everolimus, which stops cancer cells from growing and cuts their blood supply, can control advanced or recurrent ER+ endometrial cancer. About 50 adults whose cancer has returned or spread …

Matched conditions: STAGE III ENDOMETRIAL CANCER

Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC

STAGE III ENDOMETRIAL CANCER

Get alerted when new STAGE III ENDOMETRIAL CANCER trials appear

Hormone blocker plus targeted drug shows promise against tough uterine cancer